Treatment protocol – Communicable Diseases Research

Effect of a diet based on Iranian traditional medicine on inflammatory markers and clinical outcomes in COVID-19 patients: A double-blind, randomized, controlled trial

Research article

Published on 2022-10-012022-10-05
Journal: European Journal of Integrative Medicine [Category] 바이오마커, 임상,

Targeted SARS-CoV-2 treatment is associated with decreased mortality in immunocompromised patients with COVID-19

Article

Published on 2022-09-302022-11-15
Journal: Journal of Antimicrobial Chemotherapy [Category] SARS, 변종, 진단, 치료제,

Long-term survival benefit of male and multimorbid COVID-19 patients with 5-day remdesivir treatment

Observational Study

Published on 2022-08-312022-10-05
Journal: Journal of Global Health [Category] SARS, 변종, 임상,

[키워드] all-cause mortality Alpha Analysis Anemia antiviral medication benefit center clinical condition Cohort collected Comorbidity COPD coronavirus disease Course covariates COVID-19 COVID-19 pandemic COVID-19 patient diabete effective Efficacy epidemiological situation Frequency greater group hospitalized patients Hungary Inpatient lack male men Mortality multiple comorbidities multivariate Observational cohort study outcome parenchymal participant Patient performed Primary outcome RDV real-world data receiving Remdesivir retrospective risk reduction Significant significantly lower significantly more specific patient groups Standard of care supplementary oxygen survival Treatment Treatment protocol treatment regimen university Vaccinations variant
[DOI] 10.7189/jogh.12.05031 PMC 바로가기 [Article Type] Observational Study

Assessment of Tocilizumab (Humanized Monoclonal Antibody) for Therapeutic Efficacy and Clinical Safety in Patients with Coronavirus Disease (COVID-19)

코로나바이러스 감염증(COVID-19) 환자의 치료 효능 및 임상 안전성에 대한 토실리주맙(인간화 단클론항체) 평가

Article

Published on 2022-08-102022-09-12
Journal: Medicina [Category] SARS, 진단,

[키워드] activated acute respiratory distress added adverse effect airways alanine aminotransferase alkaline phosphatase ALP ALT Analysis Anticoagulant ARDS assessment Autoimmune Bacterial baseline C-reactive protein characterized clinical coagulation parameter Coagulopathy control group COVID-19 COVID-19 cases COVID-19 patient COVID-19 patients CRP CRS Cytokine release syndrome Cytokine storm D-dimer discharged Efficacy Endpoint expired fatality ferritin Follow-up humanized monoclonal antibody include infection rate Inflammatory inflammatory conditions inflammatory parameter inflammatory parameters INR institution institutional protocol International lactate dehydrogenase LDH Manifestations material normalized patients of COVID-19 Platelet Pneumonia presenting Prothrombin time provided Pulmonary edema raised receiving respiratory tract infection Result Safety severe COVID-19 patients severe disease significantly higher statistically significant difference survival rate syndrome Teaching the disease the patient therapeutic efficacy Tocilizumab treat Treatment Treatment protocol treatment regimen was performed
[DOI] 10.3390/medicina58081076 PMC 바로가기 [Article Type] Article

Comparison of Laboratory and Hemodynamic Time Series Data Across Original, Alpha, and Delta Variants in Patients With Multisystem Inflammatory Syndrome in Children

Article

Published on 2022-08-012022-11-16
Journal: Pediatric critical care medicine : a journal of th [Category] COVID19(2023년), SARS, 변종,

[키워드] acute respiratory syndrome all subject Alpha variant assist children Cohort cohort study Continuous coronavirus Delta delta variant entire cohort evaluated extracorporeal membrane oxygenation had more hemodynamic hospital Hospitalization ICU Infection Inflammatory INR Laboratory laboratory parameter Laboratory results LOS male measurement mechanical ventilation median age median value medication MIS-C Modification Mortality occurred original outcome parameter Patient Potassium Prothrombin time Sery severity sodium Symptom syndrome Tachycardia time Treatment protocol variant variants variants of concern ventricular WBCs
[DOI] 10.1097/PCC.0000000000002976 PMC 바로가기

Effectiveness of SARS-CoV-2 Vaccines for Short- and Long-Term Immunity: A General Overview for the Pandemic Contrast

단기 및 장기 면역을 위한 SARS-CoV-2 백신의 효과: 유행병 대비에 대한 일반 개요

Review

Published on 2022-07-302022-09-11
Journal: International Journal of Molecular Sciences [Category] COVID19(2023년), MERS, SARS, 변종, 진단, 치료기술, 치료제,

[키워드] ACE2 anchor Anti-spike antibodies bind booster Cell cell receptor Comorbidity concerning Contrast COVID-19 COVID-19 disease COVID-19 pandemic dentistry diagnoses disease disease severity Efficiency enzyme evaluate flu Golgi apparatus Host immunization Infection Interaction knowledge mechanism MERS mortality rate observance pandemic Patient Pfizer Primary prevention produced Protein Protein target protocol provide question reduction in Release released RNA SARS-CoV-1 SARS-CoV-2 SARS-CoV-2 disease SARS-CoV-2 variant SARS-CoV-2 variants severity significant increase spike Spike protein Spike proteins the cells the disease the SARS-CoV-2 Therapies therapy TMPRSS2 Treatment protocol treatment protocols Vaccine Vaccines Viral viral infection virion virus viruses
[DOI] 10.3390/ijms23158485 PMC 바로가기 [Article Type] Review

Clinical and laboratory profiles of the SARS-CoV-2 Delta variant compared with pre-Delta variants

델타 이전 변이와 비교한 SARS-CoV-2 Delta 변이의 임상 및 실험실 프로필

Article

Published on 2022-07-012022-09-11
Journal: International Journal of Infectious Diseases [Category] COVID19(2023년), SARS, 변종,

[키워드] activated C-reactive protein can be used Care changes in characteristic Characteristics characterized clinical Clinical data Cohort Comorbidities comparison Comparisons COVID-19 defined Delta delta variant Department Descriptive statistics ferritin fibrinogen genomic Genomics Gradient Gradient boosting model heterogeneous hospitalizations hospitalized patients Human identify implication Inflammatory intensive care intensive care unit International international normalized ratio Laboratory laboratory characteristics Lactate lactate dehydrogenase machine machine learning machine learning approach machine learning approaches Negative predictive value normalized Patient peaked phenotypical Positive predictive value Predictive value profile prothrombin Prothrombin time public health measures receiver receiver operating characteristic Research Retrospective study SARS-CoV-2 variant SARS-CoV-2 variants sensitivity service single-center specificity supported the SARS-CoV-2 the United State THROMBOPLASTIN Transmissibility Treatment protocol United States variant variants variants of concern virulence Wave Waves were used
[DOI] 10.1016/j.ijid.2022.04.050 PMC 바로가기 [Article Type] Article

Analytical Performance and Greenness Evaluation of Five Multi-Level Design Models Utilized for Impurity Profiling of Favipiravir, a Promising COVID-19 Antiviral Drug

유망한 COVID-19 항바이러스 약물인 Favipiravir의 불순물 프로파일링에 사용된 5가지 다단계 설계 모델의 분석 성능 및 친환경성 평가

Article

Published on 2022-06-072022-09-11
Journal: Molecules [Category] 치료제,

Identification, propagation and molecular characterization of SARS-CoV-2 delta variant isolated from Egyptian COVID-19 patients

이집트 COVID-19 환자에서 분리된 SARS-CoV-2 델타 변이체의 식별, 전파 및 분자 특성 분석

Article

Published on 2022-06-012022-09-11
Journal: Infection, genetics and evolution : journal of mol [Category] COVID19(2023년), SARS, 변종, 치료기술,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 addition applied B.1.617.2 beta-propiolactone causative agent cell line cell lines characterized China city clade clinically collected continuous monitoring coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 patient CPE Cytopathic effect Delta delta variant diagnosed with COVID-19 effective Effectiveness Efficacy Genetic genetic mutation Genetic variations genome sequence Genome sequences genomic sequence identification inactivated Isolation molecular Mutation rates nasopharyngeal swabs pandemic passage Patient PCR Prevalence Propagation provide qPCR reference strain Replication researcher RT-qPCR SARS-CoV-2 SARS-CoV-2 delta sequence severe acute respiratory syndrome Coronavirus Spread Swab the SARS-CoV-2 transmission rate Treatment protocol Vaccine variant variant of concern variants of concern Variation Vero E6 Vero E6 cell VERO E6 cells viral genome virus VoC was performed WGS whole genome Whole genome sequencing Wuhan-Hu-1
[DOI] 10.1016/j.meegid.2022.105278 PMC 바로가기 [Article Type] Article

Partial-Methylated HeyL Promoter Predicts the Severe Illness in Egyptian COVID-19 Patients

부분 메틸화된 HeyL 프로모터는 이집트 COVID-19 환자의 심각한 질병을 예측합니다

Article

Published on 2022-05-312022-09-12
Journal: Disease Markers [Category] MERS, 진단,

[키워드] addition alteration America approved Asia association binding Biomarkers Blood blood sample Cell cell proliferation cells clinical outcomes COVID-19 COVID-19 patient COVID-19 patients CpG demethylating agent Diseases DNA DNA sequencing dose downstream dry cough Effect element environmental factor epithelial Europe facilitate Fever Frequency GenBank genetic material Health healthy subject healthy subjects illness IMPROVE incidence methylated Methylation Modification mortality rate Notch PCR Prognostic marker promoter reference sequence Regulation Regulatory severe pneumonia subject therapy transcription factor Treatment protocol unmethylated Vaccine
[DOI] 10.1155/2022/6780710 PMC 바로가기 [Article Type] Article